Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. ALEMBIC PHARMA GENNEX LAB./
ALEMBIC PHARMA
 
P/E (TTM) x 35.6 32.1 110.9% View Chart
P/BV x 4.6 4.4 104.2% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 GENNEX LAB.   ALEMBIC PHARMA
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
ALEMBIC PHARMA
Mar-23
GENNEX LAB./
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs9792 1.1%   
Low Rs5463 1.0%   
Sales per share (Unadj.) Rs3.4287.6 1.2%  
Earnings per share (Unadj.) Rs0.317.4 1.6%  
Cash flow per share (Unadj.) Rs0.331.4 1.1%  
Dividends per share (Unadj.) Rs08.00 0.0%  
Avg Dividend yield %01.3 0.0%  
Book value per share (Unadj.) Rs4.5222.3 2.0%  
Shares outstanding (eoy) m176.64196.56 89.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.12.2 94.8%   
Avg P/E ratio x25.036.1 69.2%  
P/CF ratio (eoy) x21.020.0 105.2%  
Price / Book Value ratio x1.52.8 54.2%  
Dividend payout %046.0 0.0%   
Avg Mkt Cap Rs m1,229123,402 1.0%   
No. of employees `000NANA-   
Total wages/salary Rs m7911,691 0.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m59356,526 1.0%  
Other income Rs m4030 130.0%   
Total revenues Rs m63356,557 1.1%   
Gross profit Rs m476,772 0.7%  
Depreciation Rs m92,754 0.3%   
Interest Rs m14502 2.7%   
Profit before tax Rs m643,546 1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15126 11.5%   
Profit after tax Rs m493,420 1.4%  
Gross profit margin %7.912.0 66.0%  
Effective tax rate %22.83.6 640.8%   
Net profit margin %8.36.1 137.0%  
BALANCE SHEET DATA
Current assets Rs m48729,139 1.7%   
Current liabilities Rs m29516,408 1.8%   
Net working cap to sales %32.322.5 143.4%  
Current ratio x1.61.8 92.9%  
Inventory Days Days410 41.7%  
Debtors Days Days57,912,5897 857,093,146.4%  
Net fixed assets Rs m83531,498 2.7%   
Share capital Rs m180393 45.8%   
"Free" reserves Rs m62343,312 1.4%   
Net worth Rs m80443,705 1.8%   
Long term debt Rs m1630-   
Total assets Rs m1,32260,637 2.2%  
Interest coverage x5.78.1 70.7%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.40.9 48.2%   
Return on assets %4.76.5 73.4%  
Return on equity %6.17.8 78.3%  
Return on capital %8.09.3 86.3%  
Exports to sales %42.146.4 90.9%   
Imports to sales %13.612.1 112.2%   
Exports (fob) Rs m25026,210 1.0%   
Imports (cif) Rs m816,846 1.2%   
Fx inflow Rs m25026,210 1.0%   
Fx outflow Rs m866,846 1.3%   
Net fx Rs m16419,364 0.8%   
CASH FLOW
From Operations Rs m2377,240 3.3%  
From Investments Rs m-383-4,476 8.6%  
From Financial Activity Rs m210-2,620 -8.0%  
Net Cashflow Rs m64144 44.3%  

Share Holding

Indian Promoters % 23.6 69.1 34.2%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 0.0 19.0 -  
FIIs % 0.0 4.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 30.4 251.4%  
Shareholders   69,723 85,212 81.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GENNEX LABORATORIES vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs ALEMBIC PHARMA Share Price Performance

Period GENNEX LABORATORIES ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day 3.27% -0.45% 1.18%
1-Month -12.26% -4.58% -0.75%
1-Year 195.41% 104.81% 61.82%
3-Year CAGR 63.80% 0.79% 18.16%
5-Year CAGR 40.61% 13.50% 19.79%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.